Browse Studies — Arctuva

Phase 3

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/LY3650150 in Participants With Chronic Rhinosinusitis With Nasal Polyps on Background Intranasal Corticosteroids

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in participants with chronic rhinosinusitis and nasal polyps treated with…

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Estimated

~$10 – $7,500

Eli Lilly and CompanyNCT06338995

Observational

3D Printing for Topical Nasal Corticosteroid Irrigations: a Randomized Clinical Trial.

Three-dimensional (3D) printing has been an emerging technology with uses in a wide array of fields. This research aims to use 3D printing as a tool to provide…

Chronic Rhinosinusitis With Nasal PolypsChronic Rhinosinusitis Without Nasal Polyps

Estimated

~$10 – $6,250

Ohio State UniversityNCT06118554

Phase 1

The Role of IL5 in Epithelial Cell Integrity

The goal of this laboratory study is the examine the effect of mepolizumab drug on the health and function of the cells lining the human nasal airways in vitro…

Chronic Rhinosinusitis With Nasal PolypsChronic Rhinosinusitis (Diagnosis)

Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT05895929

Phase 2

A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study

This is a single-arm extension study to investigate the long-term safety, tolerability, and efficacy of lunsekimig in adult participants with inadequately cont…

Chronic Rhinosinusitis With Nasal Polyps

Estimated

~$10 – $7,500

SanofiNCT06914908